Healthcare Medication Research Form

HEALTHCARE MEDICATION RESEARCH FORM

Patient Information

Date of Birth:    Gender:    Phone:

Research Study Details

Principal Investigator:    Sponsor / Institution:

Medication Details

Dosage/Strength:    Route of Administration:    Frequency:

Medication Start Date:    Anticipated End Date:

Medical and Medication History

Are you pregnant, breastfeeding, or planning pregnancy? Yes No

Are you using contraception? Yes No

Insurance and Billing

Policy Number:    Group Number:    Subscriber Name:

Informed Consent and Authorization

Purpose: The undersigned consents to participate in the research study identified above. The purpose, procedures, and expected duration of medication administration have been explained. The medication is investigational for the indicated use. The subject understands that the investigational medication will be administered or provided according to the study protocol and that additional monitoring or visits may be required.

Risks and Benefits: The investigator has explained reasonably foreseeable risks, discomforts, and any potential benefits. The subject understands that there may be risks that are unknown at this time. There is no guarantee of direct clinical benefit; however, study participation may contribute to broader medical knowledge. The subject acknowledges receipt of an explanation of common and serious potential adverse effects specific to the medication described above.

Voluntary Participation and Withdrawal: Participation is voluntary. The subject may refuse to participate or may withdraw consent at any time without penalty or loss of benefits to which the subject is otherwise entitled. Withdrawing from the study will not affect future standard medical care.

Confidentiality and Data Use: Medical and research records that identify the subject will be kept confidential to the extent permitted by law. The subject authorizes the use and disclosure of protected health information to the research team, sponsor, regulatory authorities, and institutional review entities for purposes of monitoring, auditing, and analysis. De-identified data and specimens may be retained for future research. The subject understands that data may be shared in aggregate form in reports or publications without direct identifiers.

Emergency Care and Treatment of Adverse Events: The subject will be provided with local medical care for research-related adverse events. The investigator has explained procedures for reporting adverse events and provided contact information for 24-hour study reporting.

Compensation and Costs: Any compensation, travel reimbursement, or costs to the subject associated with participation have been disclosed. The subject understands whether their insurance will be billed for standard clinical care related to the study and whether the sponsor will cover study-related medical expenses.

By checking the boxes below and signing, I voluntarily consent to participate in this medication research study and authorize use and disclosure of my health information as specified.

I consent to participate in the research study described above.

I authorize the research team to use and disclose my protected health information for study purposes as described.

I agree to be contacted for future research related to this study.

I consent to genetic testing of specimens (if applicable) and understand associated risks of genetic data disclosure.

Investigator / Adverse Event Contact

24-hour Adverse Event Phone:

Patient Certification

I certify that I have read this form or that it has been read to me, that the research procedures, risks, benefits, and alternatives have been explained, and that I have had the opportunity to ask questions to my satisfaction. I understand that I will receive a signed copy of this form if requested. I understand my participation is voluntary and that I may withdraw at any time.

Sign Now